Related Experiment Video
Updated: Jun 23, 2025

10:11
Cell Co-culture Patterning Using Aqueous Two-phase Systems
Published on: March 26, 2013
18.4K
Keep Fingers on the CpG Islands.
Xing Zhang1, Robert M Blumenthal2, Xiaodong Cheng1
1Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Epigenomes
|June 26, 2024
Summary
Researchers optimized zinc-finger proteins for precise epigenetic silencing of the mouse Pcsk9 gene, a key factor in cholesterol regulation. This advancement offers potential for long-term gene silencing therapies with minimal off-target effects.
Area of Science:
- Epigenetics and Gene Regulation
- Molecular Biology
- Biotechnology
Background:
- The post-genomic era enables precise gene expression control via epigenetic editing tools.
- Reprogrammable editors with transcriptional corepressors offer potential for long-term epigenetic silencing in disease treatment.
- Ideal epigenetic editing requires precise DNA targeting, no off-target effects, and only epigenetic modifications.
Purpose of the Study:
- To enhance the specificity of zinc-finger (ZF) array DNA binding for targeted epigenetic silencing.
- To investigate optimizing amino acid-DNA base interactions for improved editor performance.
- To focus on silencing the mouse Pcsk9 gene, a regulator of cholesterol.
Main Methods:
- Utilized synthetic zinc-finger (ZF) proteins as DNA-binding editors.
- Focused on optimizing interactions between specific amino acids and DNA bases.
- Examined three promoters containing CpG islands for targeted gene silencing.
Main Results:
- Identified synthetic ZF proteins as highly effective DNA-binding editors for gene silencing.
- Demonstrated efficient, specific, and persistent silencing of the mouse Pcsk9 gene.
- Optimized ZF-array DNA binding interactions for enhanced specificity.
Conclusions:
- Optimized ZF-array DNA binding can achieve highly specific and persistent epigenetic silencing.
- This approach holds promise for developing targeted epigenetic therapies for human diseases.
- Precise control over gene expression through epigenetic editing is advancing rapidly.
Keywords:
C2H2 zinc-finger arraysCpG islands in promotersCpG-free segmentsDNA methylationDNA sequence-specific bindingepigenetic reprogrammingMore Related Videos
Related Concept Videos
The Eukaryotic Promoter Region
16.2K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
16.2K
Single Nucleotide Polymorphisms-SNPs
15.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.0K
DNA Microarrays
17.3K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
17.3K

